(Press-News.org) An implantable device that reduces blood pressure by sending electrical signals to the brain has been created by a group of researchers in Germany.
The device has successfully reduced the blood pressure in rats by 40 per cent without any major side effects, and could offer hope for a significant proportion of patients worldwide who do not respond to existing medical treatment for the condition.
The first results have been published today, 9 May, in IOP Publishing's Journal of Neural Engineering.
The device consists of 24 individual electrodes that are integrated into a micro-machined cuff. It is designed to wrap around the vagal nerve, which extends from the brainstem to the thorax and abdomen, supplying and stimulating various major organs including the heart and major blood vessels.
The device works by picking up signals from specific sensors, known as baroreceptors, which are activated when blood vessels stretch. Some baroreceptors are grouped together in concentrated areas in the aortic arch and report their information to the brainstem via fibres in the vagal nerve. These baroreceptors function to control short-term fluctuations in blood pressure.
The device has been designed to identify only those fibres that influence the blood pressure and avoid those that are responsible for heart rate, the power of heart beat, ventilation and other vital functions.
In their study, the researchers, from the University of Freiburg, tested a prototype device on five male rats. The device was 2 cm long, with a 0.8 mm diameter, and delivered 40 pulses per second to the fibres of the baroreceptors in the vagal nerve.
The researchers experimented on various areas of the vagal nerve, exploring different stimulation sites around the nerve with different frequencies, amplitudes and durations of stimulation. Using the appropriate parameters, the researchers showed that the blood pressure could be easily reduced to 60 per cent of its original value in a wide range of stimulation frequencies and pulse widths.
No major side effects, such as a significant decrease in heart rate or breathing rate, occurred when the electrode sites closest to the baroreceptor fibres were chosen for stimulation.
Lead author of the research, Dr Dennis Plachta, said: "Our proof-of-concept interface has shown that it is possible to use the left vagal nerve to reduce blood pressure without any adverse side effects, which is important for a wide variety of potential treatments that could utilise nerve stimulation without actually penetrating the nerve.
"As the device will require surgery, it is not intended to be the first port of call for treatment and will come into play when patients, for whatever reasons, are resistant to medication. Nevertheless, the long-term goal is to provide 'treatment-on-demand' for the patient, whereby the implantable device uses an intelligent circuit to record the activity of the patient, for instance when they are doing exercise, and adjust the blood pressure accordingly.
"We will now look to develop the implantable device further and investigate whether it interferes with existing medication, and ultimately test it on larger animals such as pigs and sheep."
INFORMATION:
From Friday 9 May, this paper can be downloaded from http://iopscience.iop.org/1741-2552/11/3/036011
Implantable device to beat high blood pressure
2014-05-09
ELSE PRESS RELEASES FROM THIS DATE:
Study shows short bursts of intense exercise before meals control blood sugar better than 1 continuous 30 minute session
2014-05-09
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) indicates that brief bursts of intense exercise before meals (termed exercise 'snacking' by the study authors) helps control blood sugar in people with insulin resistance more effectively than one daily 30-minute session of moderate exercise. The research was conducted by exercise science and medicine researchers, including Monique Francois and Associate Professor James Cotter from the University of Otago, Dunedin, New Zealand.
The study used a cross-over design, ...
From age 30 onwards, inactivity has greatest impact on women's lifetime heart disease risk
2014-05-09
From the age of 30 onwards, physical inactivity exerts a greater impact on a woman's lifetime risk of developing heart disease than the other well-known risk factors, suggests research published online in the British Journal of Sports Medicine.
This includes overweight, the finding show, prompting the researchers to suggest that greater effort needs to be made to promote exercise.
The researchers wanted to quantify the changing contribution made to a woman's likelihood of developing heart disease across her lifetime for each of the known top four risk factors in Australia: ...
Frequent arguments with family and friends linked to doubling in death risk in middle age
2014-05-09
Frequent arguments with partners, relatives, or neighbours may boost the risk of death from any cause in middle age, suggests research published online in the Journal of Epidemiology & Community Health.
Men and those not in work seemed to be the most vulnerable, the findings indicate.
The evidence suggests that supportive social networks and strong relationships are good for general health and wellbeing, but the authors wanted to find out if the stressors inherent in family relationships and friendships had any impact on the risk of death from any cause.
They therefore ...
Hurricanes Katrina and Rita may have caused up to half of recorded stillbirths in worst hit areas
2014-05-09
Hurricanes Katrina and Rita may have been responsible for up to half of all recorded stillbirths in the worst hit areas, suggests research published online in the Journal of Epidemiology & Community Health.
And the true fetal death toll may even be higher, because of the displacement of people whose homes and way of life were destroyed, suggest the authors.
Hurricane Katrina struck the state of Louisiana, USA, on August 29 2005, followed by Hurricane Rita a month later on September 24. Katrina was the costliest natural disaster in American history, while Rita was the ...
Super-charged tropical trees of Borneo vitally important for global carbon cycling
2014-05-09
A team of scientists has found that the woody growth of forests in north Borneo is half as great again as in the most productive forests of north-west Amazonia, an average difference of 3.2 tons of wood per hectare per year.
The new study, published today in the Journal of Ecology, examined differences in above-ground wood production (one component of the total uptake of carbon by plants) which is critically important in the global cycling of carbon.
Trees are taller for a given diameter in Southeast Asia compared with South America, meaning they gain more biomass ...
Exact outline of melanoma could lead to new diagnostic tools, therapies
2014-05-09
CORVALLIS, Ore. – Researchers at Oregon State University have identified a specific biochemical process that can cause normal and healthy skin cells to transform into cancerous melanoma cells, which should help predict melanoma vulnerability and could also lead to future therapies.
More than 70,000 cases of melanoma, the deadliest form of skin cancer, develop in the U.S. every year.
The work was published today in PLoS Genetics, in work supported by the National Institutes of Health.
"We believe this is a breakthrough in understanding exactly what leads to cancer ...
IL-27 balances the immune response to influenza and reduces lung damage
2014-05-09
Highly pathogenic (dangerous) influenza strains elicit a strong immune response which can lead to uncontrolled inflammation in the lung and potentially fatal lung injury. A study published on May 8th in PLOS Pathogens demonstrates the importance of IL-27 for the control of immunopathology—damage to the lung tissue caused by the immune system—and the therapeutic potential of well-timed IL-27 application to treat life-threatening inflammation during lung infection.
Alf Hamann, from Deutsches Rheuma-Forschungszentrum and Charité Universitätsmedizin Berlin, Germany, and colleagues, ...
SOCS4 prevents a cytokine storm and helps to clear influenza virus from the lung
2014-05-09
Certain influenza strains are highly virulent—they cause more serious disease and kill more people. Some of the damage is caused by the stronger immune response such strains elicit, especially in the lung. A study published on May 8th in PLOS Pathogens identifies SOCS4 as a key regulator of the immune response against influenza virus.
Lukasz Kedzierski, Sandra Nicholson, and colleagues from the Walter and Eliza Hall Institute of Medical Research and the University of Melbourne, Australia, studied mice with a mutation in the Socs4 gene, a member of a gene family whose ...
An extra doctor visit may help prevent rehospitalization of kidney failure patients
2014-05-09
Washington, DC (May 8, 2014) — More frequent face-to-face physician visits in the month following hospital discharge may help reduce a kidney failure patient's chances of needing to be sent back to the hospital. That's the conclusion of a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The study also found that closer outpatient monitoring of kidney failure patients following hospital discharge could cut health care costs significantly.
A major goal of health policy reform has been to reduce hospital readmissions within ...
Neurovance's EB-1020 SR for adult ADHD shows stimulant-like efficacy in Phase 2a trial
2014-05-09
Neurovance, Inc. today announced complete results from its phase 2a pilot study of EB-1020 SR, a non-stimulant, in adult male patients with all subtypes of ADHD (attention deficit hyperactivity disorder). EB-1020 SR is a norepinephrine- and dopamine-preferring triple reuptake inhibitor. The data showed a statistically significant improvement in ADHD symptoms on the ADHD-Rating Scale-IV (ADHD-RS-IV), the primary outcome measure, in a range similar to that reported in previously published trials with stimulants. EB-1020 SR appears to be well tolerated at the doses studied. ...